Pulmonary Disease in Alaska
8 providers, $15,764 in total reported payments from drug and device makers. Ranked below by lifetime general payments.
Ranking high here usually means a consulting or royalty arrangement, not wrongdoing. Payments to device inventors and trial investigators are legal, disclosed, and concentrated in a small number of people — which is exactly why a list like this has a steep top and a long flat tail.
What Medicare pays pulmonary disease clinicians in Alaska
Across 7 pulmonary disease clinicians in Alaska who billed Original Medicare Part B in 2024, Medicare allowed $675,654 in total — an average of $96,522 each, of which $96,522 was for services and the rest for drugs administered in the office.
This is not a salary. The rest is what Medicare allowed for services these clinicians billed — Original Medicare fee-for-service only. It excludes Medicare Advantage, which now covers more than half of Medicare enrollees, along with Medicaid and every commercial insurer, so for most clinicians it is a fraction of their practice. It is also gross revenue: staff, rent, supplies and malpractice premiums all come out of it before anyone is paid. Anyone quoting a figure like this as physician pay is misreading it.
Ranked by reported payments
- 1Marek MartynowiczAnchorage$11,578
- 2Dustin McLemoreAnchorage$1,154
- 3John ClarkAnchorage$975
- 4Kent StuberAnchorage$862
- 5Gregory GerbothAnchorage$550
- 6Denise WurthAnchorage$352
- 7David ZielkeAnchorage$219
- 8Beth BakerAnchorage$74